


Erectile dysfunction (ED), often called impotence, is the ongoing difficulty in getting or keeping an erection firm enough for satisfactory sexual activity. This article reviews what is known about impotence medication in clear, everyday language. It summarizes evidence from clinical guidelines and major medical organizations. It does not replace a consultation with a qualified healthcare professional.
In modern medicine, impotence medication typically refers to a group of drugs called phosphodiesterase type 5 (PDE5) inhibitors. These include:
According to guidelines from organizations such as the American Urological Association (AUA) and the European Association of Urology (EAU), PDE5 inhibitors are considered first-line medical therapy for most men with erectile dysfunction.
An erection depends on healthy blood flow. During sexual stimulation, nerves release nitric oxide in the penis. This triggers a chain reaction that relaxes smooth muscle and increases blood flow. PDE5 inhibitors support this process by blocking an enzyme (PDE5) that would otherwise reduce blood flow. The result is a stronger and longer-lasting erection in response to sexual stimulation.
Important: These medications do not automatically cause an erection. Sexual arousal is still required.
Large clinical trials show that PDE5 inhibitors improve erections in a significant proportion of men, including those with diabetes and after prostate surgery, although response rates may be lower in these groups.
Head-to-head comparisons suggest that all approved PDE5 inhibitors are broadly similar in effectiveness, but they differ in how quickly they work and how long they last. For example, tadalafil has a longer duration of action than sildenafil. For official dosing and product information, see resources such as the U.S. Food and Drug Administration (FDA) drug labels: FDA Drug Database.
PDE5 inhibitors are generally well tolerated. Common side effects include:
Less common but more serious risks include sudden vision or hearing changes and prolonged erections (priapism), which require urgent medical attention.
Critical safety warning: PDE5 inhibitors must not be used with nitrate medications (often prescribed for chest pain/angina) because the combination can cause a dangerous drop in blood pressure. Caution is also needed in people with certain heart conditions. This is why medical evaluation before starting impotence medication is strongly recommended.
Erectile dysfunction is often a symptom rather than a stand-alone disease. Common contributing factors include:
Major guidelines emphasize that ED can be an early warning sign of heart and blood vessel disease. In some men, erection problems appear years before a heart attack or stroke. Therefore, impotence medication should be seen as part of a broader health evaluation.
Be cautious with online claims of “instant” or “permanent” cures. These are rarely supported by high-quality clinical trials.
Management of erectile dysfunction usually combines medical, psychological, and lifestyle strategies. The right approach depends on the individual.
As discussed, these are first-line treatments for many men. They require a prescription in most countries. Specific dosing and timing instructions vary by drug and should be checked in official prescribing information (for example, via the European Medicines Agency or FDA website).
These are external pumps that draw blood into the penis using negative pressure. A constriction ring helps maintain the erection. Evidence supports their effectiveness, especially when medications are not suitable.
Medications such as alprostadil can be administered locally. These methods are often used when oral drugs do not work. They are effective but require training and comfort with the technique.
If blood tests show low testosterone and symptoms of deficiency, hormone therapy may be considered. However, testosterone is not a general impotence medication and does not improve erections in men with normal levels.
Performance anxiety, stress, and relationship difficulties can either cause or worsen ED. Cognitive behavioral therapy and couples therapy have supportive evidence, particularly in younger men.
For broader men’s health context, see our men’s health overview and related articles in our medical blog.
| Statement | Confidence level | Why |
|---|---|---|
| PDE5 inhibitors improve erections in many men with ED. | High | Supported by multiple large randomized controlled trials and international guidelines. |
| ED can be an early sign of cardiovascular disease. | High | Consistent findings from observational studies and reflected in cardiology/urology guidelines. |
| All PDE5 inhibitors are equally effective for all men. | Medium | Similar average effectiveness, but individual responses and duration differ. |
| Herbal supplements are as effective as prescription impotence medication. | Low | Limited high-quality trials; product variability and risk of undisclosed ingredients. |
| Combining medication with lifestyle changes improves outcomes. | Medium to high | Evidence supports risk factor control; direct combination trials are fewer but consistent with disease mechanisms. |
These steps can improve erectile function and overall health, sometimes reducing the need for higher-intensity treatments.
You may also find it helpful to read our article on understanding erectile dysfunction causes and our guide to preparing for a urology appointment.
This review reflects current mainstream medical guidance. Individual care decisions should always be made with a licensed healthcare professional.